Epsilon Research
Healthcare specialist expert network providing deep clinical and life sciences expertise to investors, pharmaceutical companies, and consultancies for due diligence and primary research.
- Healthcare-only depth
- KOL identification
- Clinical due diligence
- Boston biotech hub
- Experts
- 35K+Positioning confidence
- Employees
- 80+Partially unverifiable confidence
- Pricing
- Per-callVerified confidence
Services
- Expert Calls
- Healthcare Research
- KOL Identification
- Clinical Due Diligence
Buyer fit
Best for
- Healthcare
- Life Sciences
- Pharma DD
When not ideal
- Non-healthcare research
- Need sector diversity
- Want large generalist database
- Need self-service platform
Key strengths Positioning confidence
- Healthcare-only focus enables deeper therapeutic area expertise than generalist networks
- KOL identification capabilities for pharma and biotech
- Boston location provides access to world-class healthcare/biotech ecosystem
- Clinical and regulatory expertise for investment due diligence
Watch-outs Inference confidence
- No coverage outside healthcare and life sciences
- Smaller expert database than generalist networks
- Limited public information about funding and scale
- Less suitable for broad market research spanning multiple sectors
Deep dive
1OverviewPositioning confidence
Epsilon Research is a Boston-based expert network that specializes exclusively in healthcare and life sciences. Founded in 2017, the company connects investors, pharmaceutical companies, and consulting firms with clinical experts, Key Opinion Leaders (KOLs), and scientific specialists for due diligence, primary research, and strategic advisory.
The company's healthcare-only focus enables deeper expertise in therapeutic areas, clinical trial dynamics, regulatory pathways, and market access — areas where generalist expert networks often lack depth. Epsilon's KOL identification and mapping capabilities help pharmaceutical companies identify influential physicians and researchers in specific disease areas.
2HistoryInference confidence
Epsilon Research was founded in 2017 in Boston, choosing to specialize exclusively in healthcare and life sciences rather than competing as a generalist. The company built its expert network through relationships with clinical researchers, physicians, regulatory specialists, and healthcare executives.
- 2017Founded in Boston with exclusive healthcare and life sciences focus
- 2018-2022Built healthcare expert network to 35K+; developed KOL mapping capabilities
- 2023-2025Expanded clinical due diligence and therapeutic area coverage
3Services in detailPositioning confidence
- Healthcare Expert Consultations
- One-on-one consultations with physicians, clinical researchers, regulatory specialists, and healthcare executives across therapeutic areas.
- KOL Identification & Mapping
- AI-powered identification and mapping of Key Opinion Leaders across therapeutic areas, analyzing publication records, clinical trial involvement, and conference activity.
- Clinical Due Diligence
- Expert-supported due diligence for healthcare investments, evaluating drug pipelines, clinical trial designs, regulatory risks, and market access strategies.
4AI & platformPositioning confidence
Epsilon uses AI for KOL mapping and therapeutic area matching, analyzing clinical trial databases, publication records, and conference participation to identify healthcare experts.
- AI-powered KOL mapping and identification
- Clinical trial database analysis
- Therapeutic area matching algorithms
- Publication and citation analysis for expert credentialing
5CompliancePositioning confidence
Epsilon maintains healthcare-specific compliance protocols with strict safeguards for clinical trial information and pharma consulting conflicts.
- Healthcare-specific MNPI policies
- Clinical trial information safeguards
- Rigorous credential verification for medical professionals
- Pharma consulting conflict screening
- Audit trail for all expert interactions
6Client fitInference confidence
Ideal for organizations that need deep healthcare expertise. Not suitable for non-healthcare research.
- Life sciences investors evaluating drug pipelines and biotech targets
- Pharmaceutical companies seeking KOL identification and advisory
- Healthcare-focused PE/VC firms conducting clinical due diligence
- Medical device companies seeking regulatory and clinical expertise
7Notable factsPositioning confidence
- Healthcare-only expert network — rare pure specialization in the industry
- KOL mapping combines publication analysis, clinical trial data, and conference activity
- Boston headquarters in the heart of the US biotech/pharma corridor
8Source notes & methodology
- Epsilon Research website — company overview and services
- Expert network industry directories
- INEX ONE Expert Network Directory
9Data confidence ratings
Each data point in this profile is graded for source confidence. Here's what each badge means:
- Verified confidence
- Confirmed by official company disclosures, regulatory filings, or multiple independent sources.
- Positioning confidence
- Based on company marketing claims or self-reported data that could not be independently verified.
- Inference confidence
- Estimated or inferred from indirect evidence, third-party aggregators, or industry context.
- Partially unverifiable confidence
- Some aspects verified but full claim cannot be independently confirmed (e.g., private company financials from third-party estimates).
This profile's ratings
| Founded | Partially unverifiable confidence |
|---|---|
| Headquarters | Verified confidence |
| Expert count | Positioning confidence |
| Employee count | Partially unverifiable confidence |
| Pricing model | Verified confidence |
| Services | Positioning confidence |
| Compliance | Positioning confidence |
| Overview | Positioning confidence |
| History | Inference confidence |
| Services in detail | Positioning confidence |
| AI & platform | Positioning confidence |
| Compliance (detailed) | Positioning confidence |
| Client fit | Inference confidence |
| Strengths | Positioning confidence |
| Caveats | Inference confidence |
| Notable facts | Positioning confidence |
10How we researched this
This profile was researched and written by the ExpertNetworks.net editorial team using a multi-source methodology:
- Primary sources: Company website, press releases, SEC/regulatory filings, and official announcements
- Third-party verification: Industry reports (Integrity Research, Inex One), news coverage (TechCrunch, Bloomberg, FT), and data aggregators (PitchBook, Tracxn, Crunchbase)
- Cross-referencing: Claims were checked against multiple independent sources where possible; single-source claims are flagged
- Confidence grading: Each data point is rated as Verified, Positioning (company-claimed), or Inference (estimated from indirect evidence)
We do not accept payment from any expert network for inclusion or favorable coverage. If you spot an error, contact us with the correction and source.
Last fact-checked:
Industries served
- Healthcare
- Life Sciences
- Pharmaceuticals
- Medical Devices
- Biotechnology
Compare Epsilon Research
See Epsilon Research side by side with other providers on pricing, compliance, AI, and delivery model.
Head to head
